Image Credit: vectorfusionart/123rf.com
A new approach to breast cancer detection, utilizing artificial intelligence (AI) alongside a specialized blood screening technique, shows promise in identifying the disease at its earliest stages. A pilot study published in the Journal of Biophotonics indicates that this method could accurately detect stage 1A breast cancers with an impressive accuracy rate between 90% and 100%.
Traditionally, breast cancer detection involves imaging techniques such as mammograms, which may miss small tumors, particularly those at the early stage of 1A. This innovative method shifts focus from tumor detection to analyzing the body’s biological responses to cancer. Researchers sought to identify molecular fingerprints—unique chemical markers in the blood that signify the body’s response to the disease. These markers may originate from the cancer itself or from immune cells combating the illness.
The study employed Raman spectroscopy, an analytical tool that assesses the molecular composition of blood samples. An AI algorithm was then trained to recognize patterns linked to breast cancer. This method yielded high detection accuracy, although experts emphasize the need for larger-scale trials to validate the findings. The initial study involved only 24 patients, which limits the applicability of the results.
Moving forward, researchers are planning more extensive trials to confirm the effectiveness of this AI-powered blood screening method. If successful, it could revolutionize early breast cancer detection, allowing for less invasive treatments and significantly improving survival rates. Smaller tumors can be targeted more effectively, enhancing recovery chances for patients.
In addition to breast cancer, the research team is investigating the potential of this method for other prevalent cancers, including lung, colorectal, and prostate cancers, which together account for a significant portion of global cancer cases. As AI continues to enhance cancer diagnostics, this emerging technique may offer an additional layer of precision in early detection, transforming the landscape of cancer treatment.
Check out the original article here: Source link
